Q1 2025 13F Holders as of 31 Mar 2025
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
17,209,280
-
Total 13F shares
-
2,833,599
-
Share change
-
-344,999
-
Total reported value
-
$2,947,154
-
Put/Call ratio
-
57%
-
Price per share
-
$1.04
-
Number of holders
-
38
-
Value change
-
-$356,278
-
Number of buys
-
16
-
Number of sells
-
9
Institutional Holders of UNITY BIOTECHNOLOGY, INC. - Common Stock, par value $0.0001 per share (UNBX) as of Q1 2025
As of 31 Mar 2025,
UNITY BIOTECHNOLOGY, INC. - Common Stock, par value $0.0001 per share (UNBX) was held by
38 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
2,833,599 shares.
The largest 10 holders included
ARCH Venture Management, LLC, VANGUARD GROUP INC, Alyeska Investment Group, L.P., GEODE CAPITAL MANAGEMENT, LLC, RENAISSANCE TECHNOLOGIES LLC, BlackRock, Inc., SUSQUEHANNA INTERNATIONAL GROUP, LLP, BRIDGEWAY CAPITAL MANAGEMENT, LLC, Founders Fund V Management, LLC, and MORGAN STANLEY.
This page lists
38
institutional shareholders reporting positions in this security
for the Q1 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.